According to Amneal Pharmaceuticals
's latest financial reports the company has $91.54 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $91.54 M | 252.41% |
2022-12-31 | $25.97 M | -89.52% |
2021-12-31 | $0.24 B | -27.41% |
2020-12-31 | $0.34 B | 125.78% |
2019-12-31 | $0.15 B | -29.15% |
2018-12-31 | $0.21 B | 187.72% |
2017-12-31 | $74.16 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | 4.74% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $25.24 M | -72.42% | ๐บ๐ธ USA |